Daca-Roszak P, Swierniak M, Jaksik R, Tyszkiewicz T, Oczko-Wojciechowska M, Zebracka-Gala J, Jarzab B, Witt M, Zietkiewicz E
Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Maria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
BMC Genet. 2018 Aug 7;19(1):54. doi: 10.1186/s12863-018-0663-2.
Numerous studies have demonstrated significant differences in the expression level across continental human populations. Most of published results were performed on B-cell lines materials examined under specific laboratory conditions, without further validation in a primary biological material. The goal of our study was to identify mRNA markers characterized by a significant and stable difference in the gene expression profile in Caucasian and Chinese populations, both in the commercially available B-lymphocyte cell lines and in the primary samples of the peripheral blood.
The preliminary selection of population-differentiating transcripts was based on Illumina expression microarray analysis of the representative group of ethnically-specified B-lymphocyte cell lines. Twenty genes with the inter-population difference in the mean expression characterized by the at least 1.5-fold change and FDR < 0.05 were identified. Subsequently, a two-step validation procedure was carried out. In the first step, a subset of selected population- differentiating transcripts was tested in the independent set of B-lymphocyte cell lines, using TLDA cards. Based on TLDA analysis, three transcripts representing Fch > 2 were chosen for validation. The differentiating status was confirmed for all of them: UTS2, UGT2B17 and SLC7A7. The mean expression of UTS2 was higher in CHB (25.8-fold change compared to CEU), while the expression of UGT2B17 and SLC7A7 was higher in CEU (3.2- and 2.2-fold change, respectively). In the next validation step, two transcripts were verified in the primary biological material. As an ultimate result of our study, two mRNA markers (UTS2 and UGT2B17) exhibiting population differences in the expression level in both B-cell line and in the blood were identified. Further statistical analysis confirmed the discriminatory potential of these two markers.
An inter-population differences on the level of gene expression were identified in both B-cell lines and peripheral blood samples. These findings may have a practical application in the field of forensic science. In particular, these transcripts, targeted by specific probes, may be used as population-specific targets in the efforts aiming to separate mixture of blood from individuals of different populations. Notwithstanding, these results have to be confirmed on extended population group.
大量研究表明,不同大陆人群的基因表达水平存在显著差异。大多数已发表的研究结果是在特定实验室条件下对B细胞系材料进行的,未在原代生物材料中进一步验证。我们研究的目的是确定在白种人和中国人群中,在市售B淋巴细胞系和外周血原代样本中,基因表达谱存在显著且稳定差异的mRNA标志物。
基于对具有种族特异性的B淋巴细胞系代表性组进行Illumina表达微阵列分析,初步筛选出人群分化转录本。鉴定出20个基因,其群体间平均表达差异至少为1.5倍变化且FDR<0.05。随后,进行了两步验证程序。第一步,使用TLDA卡,在独立的B淋巴细胞系组中测试选定的人群分化转录本子集。基于TLDA分析,选择了三个Fch>2的转录本进行验证。所有转录本的差异状态均得到确认:UTS2、UGT2B17和SLC7A7。CHB中UTS2的平均表达较高(与CEU相比变化25.8倍),而CEU中UGT2B17和SLC7A7的表达较高(分别变化3.2倍和2.2倍)。在下一个验证步骤中,在原代生物材料中验证了两个转录本。作为我们研究的最终结果,鉴定出两个在B细胞系和血液中表达水平存在群体差异的mRNA标志物(UTS2和UGT2B17)。进一步的统计分析证实了这两个标志物的鉴别潜力。
在B细胞系和外周血样本中均鉴定出群体间基因表达水平的差异。这些发现可能在法医学领域有实际应用。特别是,这些被特定探针靶向的转录本,可作为群体特异性靶点,用于分离不同人群个体的血液混合物。尽管如此,这些结果还需在更大的人群组中得到证实。